Kyung Hee Lee Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2021	Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells.
3/2009	Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
1/2009	Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells.
7/2008	Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
1/2008	Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung Hee Lee Research Topics

Disease

69	Neoplasms (Cancer) 09/2022 - 01/2003
44	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2003
25	Neoplasm Metastasis (Metastasis) 04/2020 - 01/2003
11	Dementia (Dementias) 01/2022 - 03/2015
10	Pain (Aches) 07/2022 - 01/2003
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2005
7	Adenocarcinoma 01/2021 - 01/2005
6	Cancer Pain 07/2022 - 07/2012
6	Carcinoma (Carcinomatosis) 01/2020 - 02/2003
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 08/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2008
5	Disease Progression 01/2019 - 08/2004
4	Lymphatic Metastasis 09/2019 - 01/2004
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2004
4	Neutropenia 08/2015 - 01/2014
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2014 - 01/2009
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2017 - 03/2010
3	Diarrhea 08/2015 - 05/2006
3	Thrombocytopenia (Thrombopenia) 01/2015 - 08/2004
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2013 - 10/2011
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2007 - 02/2005
2	Inflammation (Inflammations) 01/2022 - 12/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2005
2	Leukemia 01/2022 - 01/2021
2	Hyperalgesia 05/2021 - 02/2010
2	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2005
2	Pneumothorax 07/2020 - 01/2019
2	Fistula 04/2020 - 05/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 04/2018
2	Seizures (Absence Seizure) 01/2019 - 01/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 01/2008
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 02/2004
2	Vomiting 11/2017 - 01/2014
2	Pancreatitis 09/2016 - 03/2005
2	Osteoarthritis 08/2016 - 01/2012

Drug/Important Bio-Agent (IBA)

23	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2003
18	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022 - 01/2003
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2021 - 07/2009
15	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2020 - 01/2003
11	Capecitabine (Xeloda)FDA Link 04/2021 - 01/2005
11	Gemcitabine FDA Link 01/2021 - 10/2008
11	Plasminogen Activators (Plasminogen Activator)IBA 04/2020 - 06/2003
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2005
9	Docetaxel (Taxotere)FDA Link 01/2019 - 08/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
8	Phosphotransferases (Kinase)IBA 12/2017 - 02/2004
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2009
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2005
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2009
6	Complementary DNA (cDNA)IBA 01/2013 - 01/2008
5	Opioid Analgesics (Opioids)IBA 07/2022 - 12/2013
5	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 03/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017 - 01/2003
5	SB 203580IBA 01/2009 - 01/2003
5	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2009 - 01/2003
5	Urokinase Plasminogen Activator ReceptorsIBA 03/2006 - 02/2003
4	Analgesics (Analgesic Drugs)IBA 07/2022 - 01/2003
4	Pharmaceutical PreparationsIBA 05/2021 - 04/2008
4	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 03/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2020 - 01/2003
4	Biological ProductsIBA 01/2019 - 01/2010
4	PlasminogenIBA 07/2008 - 01/2003
4	Monoclonal AntibodiesIBA 01/2008 - 06/2003
3	S-1 plus cisplatinIBA 01/2021 - 02/2014
3	Cadherins (E-Cadherin)IBA 04/2020 - 06/2005
3	Messenger RNA (mRNA)IBA 02/2019 - 01/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2010
3	ParaffinIBA 01/2018 - 02/2003
3	AnthracyclinesIBA 03/2014 - 08/2005
3	Interleukin-8 (Interleukin 8)IBA 01/2013 - 01/2004
3	Imatinib Mesylate (Gleevec)FDA Link 04/2012 - 01/2009
3	p38 Mitogen-Activated Protein KinasesIBA 01/2009 - 01/2003
2	AntioxidantsIBA 12/2021 - 09/2020
2	Trastuzumab (Herceptin)FDA Link 04/2021 - 03/2015
2	LigandsIBA 04/2020 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 09/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2015
2	A131 compoundIBA 01/2019 - 08/2018
2	Contrast MediaIBA 11/2018 - 11/2013
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 08/2015
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 05/2010
2	LipidsIBA 12/2017 - 03/2005
2	Methylprednisolone FDA LinkGeneric 11/2017 - 02/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2017 - 02/2006
2	EnzymesIBA 01/2017 - 06/2015

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 01/2022 - 08/2004
27	Therapeutics 01/2020 - 10/2005
15	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 08/2003
8	Long-Term Care 01/2022 - 06/2015
6	Adjuvant Chemotherapy 09/2019 - 03/2009
5	Gastrectomy 01/2022 - 01/2012
5	Radiotherapy 12/2017 - 01/2005
3	Transplantation 11/2018 - 05/2005
3	Pain Management 04/2014 - 01/2003
2	Hospice Care (Care, Bereavement) 09/2022 - 10/2019
2	Palliative Care (Palliative Therapy) 05/2021 - 03/2010
2	Chest Tubes (Chest Tube) 04/2020 - 01/2019
2	Neoadjuvant Therapy 09/2019 - 03/2014